We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Short Telomere Length Linked to Increased Risk of Heart Disease, Early Death

By LabMedica International staff writers
Posted on 29 Feb 2012
Analysis of data collected during two large prospective studies revealed that short telomere length – an indication of advanced cellular age - was associated with increased risk of myocardial infarction, ischemic heart disease, and early death. More...


Investigators at the University of Copenhagen (Denmark) measured telomere length in leukocytes from the 19,838 Danish participants in the Copenhagen City Heart Study and the Copenhagen General Population Study. Participants were followed for up to 19 years for incidents of myocardial infarction (929 cases), ischemic heart disease (2038 cases), and death (4342 cases).

Results published in the March 2012 online edition of the journal Arteriosclerosis, Thrombosis and Vascular Biology revealed that telomere length decreased linearly with increasing age in women and men in both studies. Hazard ratios were calculated as being 1.10 for myocardial infarction, 1.06 for ischemic heart disease, and 1.09 for early death per 1000–base pair decrease in telomere length. The difference in risk between those with shortest telomere length and those with longest telomere length was 50% for heart attack and 25% for early death.

“The risk of heart attack or early death is present whether your telomeres are shortened due to lifestyle or due to high age,” said senior author Dr. Borge Nordestgaard, professor of genetic epidemiology at the University of Copenhagen. “That smoking and obesity increases the risk of heart disease has been known for a while. We have now shown, as has been speculated, that the increased risk is directly related to the shortening of the protective telomeres - so you can say that smoking and obesity ages the body on a cellular level, just as surely as the passing of time.”

“Future studies will have to reveal the actual molecular mechanism by which the short telomere length causes heart attacks,” said Dr. Nordestgaard. “Does one cause the other or is the telomere length and the coronary event both indicative of a third - yet unknown - mechanism?”

Related Links:

University of Copenhagen



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Manual Pipetting Aid
Pipette Controllers macro
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.